CI INSIGHT REPORT™
In-Depth Industry Landscape Analysis for Various Therapeutic Areas in Japan
CI INSIGHT REPORT Highlights:
- In-depth Analysis of current clinical advancements for pharmaceutical products, leveraging both primary and secondary research methods in Japan
- Comprehensive Market Insights on the current state and expected evolution of the therapeutic area in Japan, including:
- Prescription Trends: Current physician practices and emerging developments in drug pipelines
- Competitor Intelligence: multi-faceted view of both new and existing players
Report Structure:
- Part 1: Overview of the industry landscape, compiled from publicly available sources.
- Part 2: Insights from quantitative surveys conducted with Tx specialists.
- Part 3: In-depth discussions with Key Opinion Leaders (KOLs), focusing on future trends and pipeline evaluations.
Report Delivery Options:
- Japanese Version (USD 15,000)
- English Translated Version (additional translation fees apply; please inquire for details)
Report List
No. | Theme Name | Release Date | Sample |
---|---|---|---|
1 | IgA nephropathy New | January 2025 | |
2 | IBD 2024 | September 2024 | |
3 | Psoriasis 2024 | May 2024 | |
4 | SSc (systemic scleroderma) | January 2024 | |
5 | NASH | September 2023 | |
6 | LN (lupus nephritis) | April 2023 | |
7 | CKD 2022 | November 2022 | |
8 | AD 2022 | June 2022 | |
9 | RA 2021 | November 2021 | |
10 | Psoriasis 2021 | June 2021 | |
11 | SLE | January 2021 | |
12 | IBD 2020 | September 2020 | |
13 | AD (atopic dermatitis) | March 2020 | |
14 | CHF (chronic heart failure) | November 2019 | |
15 | PD (Parkinson's disease) | July 2019 | |
16 | RA (rheumatoid arthritis) | December 2018 | |
17 | CKD (chronic kidney disease) | August 2018 | |
18 | Psoriasis | January 2018 | |
19 | Alzheimer's disease | July 2017 | |
20 | IBD (Crohn's disease/ulcerative colitis) | December 2016 |